Immunotherapy in mCRC
Immunotherapy in mCRC
Assoc. Prof. Gerald Prager
Associate Professor Dr. Gerald Prager, from the Medical University of Vienna (Austria) has summarised the insights from clinical data on immunotherapy in mCRC (2015).Assoc. Prof. Gerald Prager
Medical Oncologist
Medical University of Vienna
Austria
Assoc. Prof. Gerald Prager has received financial support/sponsorship for research support, consultation, or speaker fees from the following companies:
| 5 min | 2015
This programme was made for you: your opinion matters
Share your feedback in just 4 clicks and help us to continue to create the content you need.
I agree that this educational programme:
Was valuable to me:
1/4
Has improved my knowledge of this topic:
2/4
Is likely to change my clinical practice:
3/4
Was balanced and unbiased:
4/4
download resources
This programme was made for you: your opinion matters
Share your feedback in just 4 clicks and help us to continue to create the content you need.
I agree that this educational programme:
Was valuable to me:
1/4
Has improved my knowledge of this topic:
2/4
Is likely to change my clinical practice:
3/4
Was balanced and unbiased:
4/4
GI CONNECT is an initiative of COR2ED, supported by an Independent Educational Grant from Bayer.